Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years
Biotest, a Grifols Group company, is expected to launch its recently FDA-approved intravenous immunoglobulin in the U.S. in first quarter […]
Biotest, a Grifols Group company, is expected to launch its recently FDA-approved intravenous immunoglobulin in the U.S. in first quarter […]
Seoul, South Korea, July 01, 2024 (GLOBE NEWSWIRE) — GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and […]
Experienced Financial Executive Joins Fast-Growing Global Franchising Company LOS ANGELES, July 01, 2024 (GLOBE NEWSWIRE) — FAT (Fresh. Authentic. Tasty.) […]
RESEARCH TRIANGLE PARK, N.C., July 01, 2024 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage […]
AUSTIN, TX & DURHAM, NC, July 01, 2024 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology […]
Company Achieved New Record-High Monthly and Quarterly Deliveries NIO delivered 21,209 vehicles in June 2024, increasing by 98.1% year-over-year NIO delivered […]
01 July 2024, 11.30 CET ArcelorMittal (’the Company’) has today filed its 2023 Payments to Governments in respect of Extractive […]
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today […]
GUANGZHOU, China, July 01, 2024 (GLOBE NEWSWIRE) — XPeng Inc. (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a […]
BEIJING, China, July 01, 2024 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), […]